BCR–JAK2 drives a myeloproliferative neoplasm in transplanted mice

E-ISSN： 1555-2039|236|2|219-228

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.236, Iss.2, 2015-06, pp. : 219-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR–JAK2 fusion transcript

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 97, Iss. 4, 2016-10 ,pp. : 399-402

John Wiley & Sons Inc

Access to resources Recommend Favorite

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2^V617F Mutation Status

Acta Haematologica, Vol. 126, Iss. 1, 2011-04 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd‐Chiari Syndrome without myeloproliferative neoplasm

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 3, 2018-02 ,pp. : 443-445

John Wiley & Sons Inc

Access to resources Recommend Favorite

JAK2 and MPL Mutations in Myeloproliferative Neoplasms

Acta Haematologica, Vol. 119, Iss. 4, 2008-06 ,pp. : 218-225

Karger

Access to resources Recommend Favorite

Leukocytosis, JAK2^V617F Mutation, and Hemostasis in Myeloproliferative Disorders

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 148-159

Karger

Access to resources Recommend Favorite